Evaluation of the Swedish National Stroke Campaign: A population-based time-series study

Annika Nordanstig(Sahlgrenska University Hospital), Lars Rosengren(Sahlgrenska University Hospital), Bo Norrving(Lund University), Kjell Asplund(Umeå University), Nils Wahlgren(Karolinska Institutet), Bo Palaszewski(Region Västra Götaland), Per Wester(Karolinska Institutet), Katarina Jood(Sahlgrenska University Hospital)
International Journal of Stroke
April 10, 2019
10.1177/1747493019840939
Cited by 16

Related Papers

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
|The Lancet|2014|2.7k
Priority actions for the non-communicable disease crisis
|The Lancet|2011|1.6k
Action Plan for Stroke in Europe 2018–2030
|European Stroke Journal|2018|601
Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF
|Journal of Neurochemistry|1996|502